Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: A prospective observational study

Critical Care

Volumn 18, Issue 1, 2014, Pages

  Koyama, Kansuke ^a   Madoiwa, Seiji ^a   Nunomiya, Shin ^a   Koinuma, Toshitaka ^a   Wada, Masahiko ^a   Sakata, Asuka ^a   Ohmori, Tsukasa ^a   Mimuro, Jun ^a   Sakata, Yoichi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; ANTITHROMBIN III-PROTEASE COMPLEX; BIOLOGICAL MARKER; PEPTIDE HYDROLASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C;

AGED; BLOOD; BLOOD CLOTTING; BLOOD COAGULATION DISORDERS; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; SEPSIS; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTITHROMBIN III; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSPECTIVE STUDIES; PROTEIN C; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 84892420346     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13190     Document Type: Article

References (33)

1. Kinasewitz GT, Yan SB, Basson B, Comp P, Russell JA, Cariou A, Um SL, Utterback B, Laterre PF, Dhainaut JF, PROWESS Sepsis Study Group Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care 2004, 8:R82-R90. 10.1186/cc2459, 420030, 15025782, PROWESS Sepsis Study Group.
2. Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999, 341:586-592. 10.1056/NEJM199908193410807, 10451465.
3. Zeerleder S, Hack CE, Wuillemin WA. Disseminated intravascular coagulation in sepsis. Chest 2005, 128:2864-2875. 10.1378/chest.128.4.2864, 16236964.
4. Taylor FB, Toh CH, Hoots WK, Wada H, Levi M, Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001, 86:1327-1330. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH).
5. Dhainaut JF, Yan SB, Joyce DE, Pettila V, Basson B, Brandt JT, Sundin DP, Levi M. Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2004, 2:1924-1933. 10.1111/j.1538-7836.2004.00955.x, 15550023.
6. Oh D, Jang MJ, Lee SJ, Chong SY, Kang MS, Wada H. Evaluation of modified non-overt DIC criteria on the prediction of poor outcome in patients with sepsis. Thromb Res 2010, 126:18-23. 10.1016/j.thromres.2009.12.008, 20079919.
7. Angstwurm MW, Dempfle CE, Spannagl M. New disseminated intravascular coagulation score: a useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores. Crit Care Med 2006, 34:314-320. quiz 328, 10.1097/01.CCM.0000196832.27501.B2, 16424708.
8. Voves C, Wuillemin WA, Zeerleder S. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients. Blood Coagul Fibrinolysis 2006, 17:445-451. 10.1097/01.mbc.0000240916.63521.2e, 16905947.
9. Ten Cate H. Trombocytopenia: one of the markers of disseminated intravascular coagulation. Pathophysiol Haemost Thromb 2003, 33:413-416. 10.1159/000083838, 15692253.
10. Song J, Hu D, He C, Wang T, Liu X, Ma L, Lin Z, Chen Z. Novel biomarkers for early prediction of sepsis-induced disseminated intravascular coagulation in a mouse cecal ligation and puncture model. J Inflamm (Lond) 2013, 10:7. 10.1186/1476-9255-10-7, 3637617, 23497204.
11. Toh CH, Downey C. Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2005, 16:69-74. 10.1097/00001721-200501000-00011, 15650549.
12. Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med 2010, 38:S26-S34.
13. O'Brien M. The reciprocal relationship between inflammation and coagulation. Top Companion Anim Med 2012, 27:46-52. 10.1053/j.tcam.2012.06.003, 23031455.
14. Koyama K, Madoiwa S, Tanaka S, Koinuma T, Wada M, Sakata A, Ohmori T, Mimuro J, Nunomiya S, Sakata Y. Evaluation of hemostatic biomarker abnormalities that precede platelet count decline in critically ill patients with sepsis. J Crit Care 2013, 28:556-563. 10.1016/j.jcrc.2012.10.069, 23583072.
15. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, International Sepsis Definitions Conference SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2001, 2003(29):530-538. International Sepsis Definitions Conference.
16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829. 10.1097/00003246-198510000-00009, 3928249.
17. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710. 10.1007/BF01709751, 8844239.
18. Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, Mayumi T, Murata A, Ikeda T, Ishikura H, Ueyama M, Ogura H, Kushimoto S, Saitoh D, Endo S, Shimazaki S, Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med 2006, 34:625-631. Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group.
19. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008, 34:17-60. Erratum in: Intensive Care Med 2008, 34:783-785, 10.1007/s00134-007-0934-2, 2249616, 18058085.
20. Amaral A, Opal SM, Vincent JL. Coagulation in sepsis. Intensive Care Med 2004, 30:1032-1040. 10.1007/s00134-004-2291-8, 15148567.
21. Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, Laszik Z, Esmon CT, Heyderman RS. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001, 345:408-416. 10.1056/NEJM200108093450603, 11496851.
22. Levi M, van der Poll T. The role of natural anticoagulants in the pathogenesis and management of systemic activation of coagulation and inflammation in critically ill patients. Semin Thromb Hemost 2008, 34:459-468. 10.1055/s-0028-1092876, 18956286.
23. Bergmann S, Hammerschmidt S. Fibrinolysis and host response in bacterial infections. Thromb Haemost 2007, 98:512-520.
24. Madoiwa S, Nunomiya S, Ono T, Shintani Y, Ohmori T, Mimuro J, Sakata Y. Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation. Int J Hematol 2006, 84:398-405. 10.1532/IJH97.05190, 17189219.
25. Lorente JA, Garcia-Frade LJ, Landin L, de Pablo R, Torrado C, Renes E, Garcia-Avello A. Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 1993, 103:1536-1542. 10.1378/chest.103.5.1536, 8486040.
26. Saetre T, Lindgaard AK, Lyberg T. Systemic activation of coagulation and fibrynolysis in a porcine model of serogroup A streptococcal shock. Blood Coagul Fibrinolysis 2000, 11:433-438. 10.1097/00001721-200007000-00006, 10937804.
27. Kinasewitz GT, Zein JG, Lee GL, Nazir SA, Taylor FB. Prognostic value of a simple evolving disseminated intravascular coagulation score in patients with severe sepsis. Crit Care Med 2005, 33:2214-2221. 10.1097/01.CCM.0000181296.53204.DE, 16215373.
28. Dhainaut JF, Shorr AF, Macias WL, Kollef MJ, Levi M, Reinhart K, Nelson DR. Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med 2005, 33:341-348. 10.1097/01.CCM.0000153520.31562.48, 15699837.
29. Iba T, Gando S, Murata A, Kushimoto S, Saitoh D, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, Mayumi T, Ikeda T, Ishhikura H, Ueyama M, Ogura Y, Endo S, Shimazaki S, Japanese Association for Acute Medicine Disseminated Intravascular Coagulation Study Group Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers. J Trauma 2007, 63:1093-1098. 10.1097/01.ta.0000251420.41427.d3, 17993956, Japanese Association for Acute Medicine Disseminated Intravascular Coagulation Study Group.
30. Iba T, Kidokoro A, Fukunaga M, Sugiyama K, Sawada T, Kato H. Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers. Shock 2005, 23:25-29. 10.1097/01.shk.0000144422.32647.b6, 15614127.
31. Egi M, Morimatsu H, Wiedermann CJ, Tani M, Kanazawa T, Suzuki S, Matsusaki T, Shimizu K, Toda Y, Iwasaki T, Morita K. Non-overt disseminated intravascular coagulation scoring for critically ill patients: the impact of antithrombin levels. Thromb Haemost 2009, 101:696-705.
32. Kienast J, Juers M, Wiedermann CJ, Hoffmann JN, Ostermann H, Strauss R, Keinecke HO, Warren BL, Opal SM, KyberSept Investigators Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 2006, 4:90-97. KyberSept Investigators.
33. Mavrommatis AC, Theodoridis T, Economou M, Kotanidou A, El Ali M, Christopoulou-Kokkinou V, Zakynthinos SG. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock. Intensive Care Med 2001, 27:1853-1859. 10.1007/s00134-001-1139-8, 11797019.